ReCor Medical is an early stage medical device company developing an innovative technology for the treatment of structural heart disease.

Read More

• 4,000,000 people in US have Mitral Valve insufficiency.
• 250,000 new diagnoses each year.
• Only 50,000 are currently treated by surgery (Replacement or Repair).

• A catheter-based approach to mitral annuloplasty.
• Utilizes therapeutic ultrasound to shrink the collagen-rich mitral annulus.
• No surgical implantation.